Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors

February 3, 2011 2:37 am | by Bio-Medicine.Org | News | Comments

MENLO PARK, Calif., Feb. 3, 2011 /- Corium International, Inc., a privately-held advanced transdermal drug delivery company, today announced the appointment of Dr. Bhaskar Chaudhuri and David L. Greenwood to the Board of Directors.  Dr. Chaudhuri most recently served as President of...

Inspiration Biopharmaceuticals Demonstrates Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B

February 2, 2011 10:36 pm | by Bio-Medicine.Org | News | Comments

GENEVA, Feb. 3, 2011 /- Inspiration Biopharmaceuticals, Inc. (Inspiration) today presented pharmacokinetic (PK) data on its lead product, IB1001, a recombinant factor IX (FIX) for the treatment and prevention of bleeding in individuals with hemophilia B.  Results of the Phase 1...

Sonoma Orthopedic Products® Announces Key License and Distribution Agreement for Japan

February 2, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Feb. 2, 2011 /- Sonoma Orthopedic Products announced that it has entered into a licensing and distribution agreement with Ai-Medic, a subsidiary of Olympus® Business Creation Corporation.  Ai-Medic is a leading supplier of orthopedic products in the Japanese...

Advertisement

Inovio Pharmaceuticals' Dual-Antigen SynConâ„¢ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial

February 2, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., Feb. 2, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper in the journal Human Vaccines detailing potent...

Dawn Phillips Named as Vice President, Business Development for Catastrophic & Home Health Services

February 2, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

JACKSONVILLE, Fla., Feb. 2, 2011 /- MSC, a leader in care management solutions serving post-injury workers' compensation patients announced today that Dawn Phillips has been named Vice President of Business Development for its Catastrophic & Home Health Services division....

Reportlinker Adds Pen Injectors

February 1, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pen Injectors http://www.reportlinker.com/p0369406/Pen-Injectors.html User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable...

Inflammation Identified as New Therapeutic Target Years After Stroke

February 1, 2011 10:33 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Feb. 1, 2011 /- A breakthrough in stroke research identifying the potential reversibility of chronic neurologic disability in stroke survivors has published today. In the February 1, 2011 issue of the journal CNS Drugs the first human results of a new method of targeting...

The 'Me-Covery': Saatchi & Saatchi Wellness and Time Inc.'s Health Brand Reveal Historic Shift in Female Consumer Behavior

February 1, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 1, 2011 /- American women are recovering from the economic crisis by prioritizing their own physical and emotional wellness in choices about their spending and brand selection, according to results from a new national consumer survey conducted by Saatchi & Saatchi...

Advertisement

Calling All 24/7 Moms! Ester-C - The Better Vitamin C, announces the launch of '24/7 Mom Contest'

February 1, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

BOHEMIA, N.Y., Feb. 1, 2011 /- Ester-C® is proud to announce the launch of the 24/7 Mom Contest, a contest designed to pay tribute to the unsung heroes in our lives – our moms. Do you know a mom who can juggle the house, the kids, scheduling, work and so much more? Then cast...

Canada's Windsor-Essex Region Collaborates With IBM to Improve Quality of Life for Citizens

February 1, 2011 4:35 am | by IBM | News | Comments

The region of Windsor-Essex, Ontario, Canada, today announced that it is using social business technology from IBM (NYSE: IBM) to significantly improve the quality of life for its citizens. E-mail this page Save to del.icio.us Digg this

PCMA: Ohio's Medicaid Program Could Save $135 Million

January 31, 2011 10:37 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Jan. 31, 2011 /PRNewswire-USNewswire/ -- Ohio's Medicaid program could cost taxpayers an additional $1.6 billion next year, a 49 percent jump in the state's share of costs for the health care program covering more than 2 million poor and disabled Ohioans, according to new...

New Interim Leadership for USP-Brazil

January 31, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Jan. 31, 2011 /PRNewswire-USNewswire/ -- To further its continuing partnerships with Brazilian public health authorities and pharmaceutical manufacturers, the U.S. Pharmacopeial Convention (USP) has appointed Mr. Nelson dos Santos as interim vice president of its Sao...

PDI to Present at the UBS 21st Annual Global Healthcare Services Conference

January 31, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Jan. 31, 2011 /- PDI, Inc. (Nasdaq: PDII ) today announced that Nancy Lurker, the company's chief executive officer, is scheduled to present at the UBS 21st Annual Global Healthcare Services Conference at 3:30 pm ET on February 8, 2011 at the Grand Hyatt New York. The...

Advertisement

Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SANTA FE, N.M. and PRINCETON, N.J., Jan. 31, 2011 /- Qforma, the leading provider of advanced analytics and predictive modeling technologies for the health sciences industry, today announced the appointments of Ted Pine and Devon Reimer as Vice Presidents of Business Development, and...

Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SHAWNEE, Kan., Jan. 31, 2011 /- Bayer Animal Health announced this month at the North American Veterinary Conference, the availability of its new products:  Advantage® II for cats and dogs, and K9 Advantix® II for dogs.  These products combine the adulticidal...

Amarin Provides 2010 Year-End Review to Shareholders

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

DUBLIN and MYSTIC, Conn., Jan. 31, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today issued a special letter to its shareholders. The text of the letter, written by Joseph S. Zakrzewski, Executive...

ClinOps to Change Name to Emphusion

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Jan. 31, 2011 /- ClinOps is a specialized contract research organization with a core service offering combining expert data management, biostatistics and specialized clinical services. Emphusion targets development programs in biotechnology, medical device, and...

Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Jan. 31, 2011 /- Laureate Pharma, Inc. has changed its name to Laureate Biopharmaceutical Services, Inc. (Laureate Biopharma) to better describe the company's positioning in the biopharmaceutical industry.  The company's logo has been updated to emphasize "Laureate"...

Endologix Announces Favorable Clinical Results for Nellix Technology

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Jan. 31, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm (EVAR)....

Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

GREENWICH, Conn., Jan. 31, 2011 /- Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator. The Mederi RF Generator powers the Stretta® System for treatment of Gastroesophageal Reflux Disease (GERD) as well as the Secca®...

Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Jan. 31, 2011 /- Attorneys at Lewitt, Hackman, Shapiro, Marshall & Harlan, a southern California law firm, filed a lawsuit regarding a Johnson & Johnson recall of DePuy metal on metal hip replacement devices. The firm filed the suit against DePuy Orthopedics, Inc. and...

Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System

January 31, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Jan. 31, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved its Renegade® HI-FLO™ Fathom® Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic...

Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification

January 30, 2011 11:35 pm | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Jan. 31, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc.,  have received a Paragraph IV Certification Notice from Mylan Technologies Inc. advising of the filing of an Abbreviated...

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2011

January 30, 2011 1:31 pm | by Bio-Medicine.Org | News | Comments

DETROIT, Jan. 30, 2011 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for...

Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.

January 28, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

DENVER, Jan. 28, 2011 /- Burg Simpson Eldredge Hersh & Jardine, P.C., one of the nation's leading plaintiff litigation law firms, is delighted to announce that shareholder, Seth. A. Katz, has been appointed by the Hon. David A. Katz to serve as a member of the Plaintiffs' Steering...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading